Protocol for an open-label, randomised, controlled trial to evaluate the efficacy and safety of sotatercept add-on therapy compared with pulmonary vasodilator-based standard of care for pulmonary vasodilator-resistant pulmonary arterial hypertension associated with unrepaired congenital shunts (atrial septal defect, ventricular septal defect or patent ductus arteriosus), including Eisenmenger syndrome: the SuMILE trial
一项开放标签、随机、对照试验方案，旨在评估索他西普附加疗法与基于肺血管扩张剂的标准治疗方案相比，对未修复的先天性分流（房间隔缺损、室间隔缺损或动脉导管未闭）相关的肺血管扩张剂抵抗性肺动脉高压（包括艾森门格综合征）的疗效和安全性：SuMILE试验
期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2025-113430
Yoshida, Keimei; Hosokawa, Kazuya; Hiraide, Takahiro; Akagi, Satoshi; Ejiri, Kentaro; Taniguchi, Yu; Adachi, Shiro; Inami, Takumi; Nakanishi, Naohiko; Kataoka, Masaharu; Satoh, Taijyu; Tatebe, Shunsuke; Shinke, Toshiro; Tomita, Hideshi; Akazawa, Yusuke; Higaki, Takashi; Tagawa, Koshiro; Ishikita, Ayako; Asakawa, Soshun; Abe, Kohtaro
